Reinforced HEAV'D therapy for adult acute lymphoblastic leukemia: Improved results and revised prognostic criteria
- 1 January 1993
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 11 (4) , 169-177
- https://doi.org/10.1002/hon.2900110402
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Idarubicin in the Initial Treatment of Adults with Acute Lymphoblastic Leukemia: The Effect of Drug Schedule on OutcomeLeukemia & Lymphoma, 1993
- Intensive retreatment of adults and children with acute lymphoblastic leukemiaHematological Oncology, 1992
- Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemiaAnnals of Hematology, 1992
- The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.Journal of Clinical Oncology, 1991
- Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reactionThe Lancet, 1991
- Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- The importance of cytogenetic studies in adult acute lymphocytic leukemiaThe American Journal of Medicine, 1990
- Intensive Retreatment of Childhood Acute Lymphoblastic Leukemia in First Bone Marrow RelapseNew England Journal of Medicine, 1986
- Treatment of acute lymphoblastic leukemia in adultsHematological Oncology, 1985
- A RAPID BANDING TECHNIQUE FOR HUMAN CHROMOSOMESThe Lancet, 1971